Granath Carl, Noren Hunter, Björck Hanna, Simon Nancy, Olesen Kim, Rodin Sergey, Grinnemo Karl-Henrik, Österholm Cecilia
Division of Cardiothoracic Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Cell Therapy Institute, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, Florida, USA.
Biores Open Access. 2020 Dec 7;9(1):269-278. doi: 10.1089/biores.2020.0018. eCollection 2020.
Aortic valve stenosis is one of the most common cardiovascular diseases in western countries and can only be treated by replacement with a prosthetic valve. Tissue engineering is an emerging and promising treatment option, but in-depth knowledge about the microstructure of native heart valves is lacking, making the development of tissue-engineered heart valves challenging. Specifically, the basement membrane (BM) of heart valves remains incompletely characterized, and decellularization protocols that preserve BM components are necessary to advance the field. This study aims to characterize laminin isoforms expressed in healthy human aortic valves and establish a small animal decellularized aortic valve scaffold for future studies of the BM in tissue engineering. Laminin isoforms were assessed by immunohistochemistry with antibodies specific for individual α, β, and γ chains. The results indicated that LN-411, LN-421, LN-511, and LN-521 are expressed in human aortic valves ( = 3), forming a continuous monolayer in the endothelial BM, whereas sparsely found in the interstitium. Similar results were seen in rat aortic valves ( = 3). Retention of laminin and other BM components, concomitantly with effective removal of cells and residual DNA, was achieved through 3 h exposure to 1% sodium dodecyl sulfate and 30 min exposure to 1% Triton X-100, followed by nuclease processing in rat aortic valves ( = 3). Our results provide crucial data on the microenvironment of valvular cells relevant for research in both tissue engineering and heart valve biology. We also describe a decellularized rat aortic valve scaffold useful for mechanistic studies on the role of the BM in heart valve regeneration.
主动脉瓣狭窄是西方国家最常见的心血管疾病之一,目前只能通过人工瓣膜置换进行治疗。组织工程是一种新兴且有前景的治疗选择,但目前缺乏对天然心脏瓣膜微观结构的深入了解,这使得组织工程心脏瓣膜的研发面临挑战。具体而言,心脏瓣膜的基底膜(BM)仍未得到充分表征,因此需要能够保留BM成分的去细胞化方案来推动该领域的发展。本研究旨在表征健康人主动脉瓣中表达的层粘连蛋白异构体,并建立一种小动物去细胞化主动脉瓣支架,用于未来组织工程中BM的研究。通过使用针对单个α、β和γ链的特异性抗体进行免疫组织化学评估层粘连蛋白异构体。结果表明,LN-411、LN-421、LN-511和LN-521在人主动脉瓣(n = 3)中表达,在内皮BM中形成连续单层,而在间质中稀疏分布。在大鼠主动脉瓣(n = 3)中也观察到了类似结果。通过将大鼠主动脉瓣(n = 3)暴露于1%十二烷基硫酸钠3小时和1% Triton X-100 30分钟,然后进行核酸酶处理,实现了层粘连蛋白和其他BM成分的保留,同时有效去除了细胞和残留DNA。我们的结果为组织工程和心脏瓣膜生物学研究中与瓣膜细胞微环境相关的关键数据提供了依据。我们还描述了一种去细胞化大鼠主动脉瓣支架,可用于BM在心脏瓣膜再生中作用的机制研究。